You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 7,745,409


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 7,745,409 protect, and when does it expire?

Patent 7,745,409 protects LINZESS and is included in one NDA.

This patent has eighty-seven patent family members in twenty-eight countries.

Summary for Patent: 7,745,409
Title:Methods and compositions for the treatment of gastrointestinal disorders
Abstract: The present invention features compositions and related methods for treating IBS and other gastrointestinal disorders and conditions (e.g., gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), Crohn's disease, ulcerative colitis, Inflammatory bowel disease, functional heartburn, dyspepsia (including functional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), and disorders and conditions associated with constipation, e.g., constipation associated with use of opiate pain killers, post-surgical constipation (post-operative ileus), and constipation associated with neuropathic disorders as well as other conditions and disorders using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.
Inventor(s): Currie; Mark G. (Sterling, MA), Mahajan-Miklos; Shalina (Stanford, CA), Norman; Thea (San Diego, CA), Milne; G. Todd (Brookline, MA)
Assignee: Ironwood Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:11/949,340
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,745,409
Patent Claim Types:
see list of patent claims
Compound; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,745,409: A Comprehensive Analysis

Introduction

Patents are a cornerstone of innovation, protecting intellectual property and encouraging the development of new technologies. The United States Patent 7,745,409, hereafter referred to as the '409 patent, is a significant example of how patents shape the intellectual property landscape. This article delves into the scope, claims, and broader patent landscape surrounding this patent.

Background of the '409 Patent

To begin with, it is crucial to understand the context in which the '409 patent was granted. The patent system in the United States is governed by the U.S. Patent and Trademark Office (USPTO), which has undergone several changes over the years, such as those introduced by the Leahy-Smith America Invents Act (AIA) in 2011[1].

Patent Claims and Scope

The '409 patent, like any other, is defined by its claims, which outline the specific invention and its boundaries. The claims section is critical because it determines the scope of protection afforded to the patent holder. Here are some key points to consider:

Claim Structure

Patent claims are typically structured in a hierarchical manner, with independent claims standing alone and dependent claims referencing back to the independent claims. The '409 patent would follow this structure, ensuring clarity and specificity in what is being claimed[3].

Claim Types

There are different types of claims, including method claims, apparatus claims, and composition of matter claims. Understanding which type of claim is involved in the '409 patent helps in grasping its applicability and scope.

Claim Interpretation

The interpretation of patent claims is a legal process that involves determining the meaning and scope of the claims. This is often a point of contention in patent litigation, as seen in cases like JANSSEN PHARMACEUTICALS, INC. v. TEVA, where the interpretation of claims related to dosing regimens was central to the dispute[5].

Patent Landscape: Trends and Statistics

The patent landscape around the '409 patent is influenced by broader trends in patent litigation and the types of patents being granted.

Increase in Patent Litigation

From 2000 to 2011, there was a notable increase in patent infringement lawsuits, particularly in the software sector. This increase was partly due to the anticipation of changes in the AIA, which led to more lawsuits being filed to avoid the new limitations on the number of defendants in a single lawsuit[1].

Role of Nonpracticing Entities (NPEs)

Nonpracticing entities, often referred to as patent trolls, play a significant role in patent litigation. They were responsible for about a fifth of all patent infringement lawsuits during the period studied by the GAO. Understanding the role of NPEs is crucial in assessing the patent landscape[1].

Software-Related Patents

Software-related patents have been a major contributor to the increase in patent litigation. The '409 patent, if related to software, would be part of this trend, which has significant implications for the tech industry[1].

Impact of the Leahy-Smith America Invents Act (AIA)

The AIA introduced several changes to the U.S. patent system, including the transition from a first-to-invent to a first-to-file system and changes in the rules for joinder in patent litigation. These changes have had a profound impact on how patents are filed, litigated, and enforced[1].

Small Claims Patent Court: A Potential Solution

There has been ongoing discussion about the feasibility of a small claims patent court to handle lower-stakes patent disputes more efficiently. This concept, studied by the Administrative Conference of the United States (ACUS), aims to provide a more accessible and cost-effective forum for resolving patent disputes, which could affect the landscape around patents like the '409 patent[2].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides valuable insights into patent claims and their scope. This dataset, which includes detailed information on claims from U.S. patents granted between 1976 and 2014, can be used to analyze trends and patterns in patent claims, including those related to the '409 patent[3].

Advanced Patent Searching

Advanced patent searching tools, such as those provided by the USPTO and international databases like PATENTSCOPE, are essential for navigating the complex patent landscape. These tools allow for full-text searching of patent grants and applications, facilitating the identification of relevant patents and understanding their scope[4].

Litigation and Enforcement

Patent litigation is a critical aspect of the patent landscape. Cases like JANSSEN PHARMACEUTICALS, INC. v. TEVA highlight the complexities involved in enforcing patent rights. The '409 patent, if involved in litigation, would need to withstand legal scrutiny regarding its claims and scope[5].

Expert Insights and Industry Perspectives

Industry experts and legal practitioners often provide valuable insights into the patent landscape. For instance, the consultative group advising ACUS on the small claims patent court study includes experts from various legal and academic backgrounds, offering diverse perspectives on patent litigation and reform[2].

Economic and Policy Considerations

The economic and policy implications of patents are significant. The USPTO's efforts to improve patent quality and the patent examination process are ongoing. Linking trends in patent litigation to internal data on patent examination can help in improving the overall quality of issued patents[1].

Key Takeaways

  • Patent Claims: The scope and claims of a patent define its boundaries and are crucial for understanding its protection.
  • Patent Landscape: Trends in patent litigation, the role of NPEs, and the impact of the AIA are key factors shaping the patent landscape.
  • Small Claims Court: The potential for a small claims patent court could change how lower-stakes patent disputes are handled.
  • Advanced Searching: Tools like the USPTO's Patent Claims Research Dataset and international databases are essential for navigating the patent landscape.
  • Litigation: Patent litigation is complex and critical for enforcing patent rights.

FAQs

What is the significance of the Leahy-Smith America Invents Act (AIA) in patent law?

The AIA introduced significant changes to the U.S. patent system, including the transition from a first-to-invent to a first-to-file system and changes in the rules for joinder in patent litigation, which have impacted how patents are filed, litigated, and enforced[1].

How do nonpracticing entities (NPEs) influence patent litigation?

NPEs, or patent trolls, were responsible for about a fifth of all patent infringement lawsuits during the period studied by the GAO. They play a significant role in shaping the patent landscape and are often involved in litigation[1].

What is the purpose of the USPTO's Patent Claims Research Dataset?

The dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and is used to analyze trends and patterns in patent claims, helping to understand the scope and complexity of patents[3].

How does advanced patent searching aid in understanding the patent landscape?

Advanced patent searching tools allow for full-text searching of patent grants and applications, facilitating the identification of relevant patents and understanding their scope. This is crucial for navigating the complex patent landscape[4].

What is the potential impact of a small claims patent court on the patent landscape?

A small claims patent court could provide a more accessible and cost-effective forum for resolving lower-stakes patent disputes, potentially reducing the burden on the traditional court system and making patent enforcement more efficient[2].

Sources

  1. GAO Report: Assessing Factors That Affect Patent Infringement Litigation[1].
  2. ACUS Study: U.S. Patent Small Claims Court[2].
  3. USPTO Dataset: Patent Claims Research Dataset[3].
  4. Clemson LibGuide: Advanced Patent Searching[4].
  5. CAFC Opinion: JANSSEN PHARMACEUTICALS, INC. v. TEVA[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,745,409

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Abbvie LINZESS linaclotide CAPSULE;ORAL 202811-003 Jan 25, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y ⤷  Subscribe
Abbvie LINZESS linaclotide CAPSULE;ORAL 202811-001 Aug 30, 2012 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y Y ⤷  Subscribe
Abbvie LINZESS linaclotide CAPSULE;ORAL 202811-002 Aug 30, 2012 RX Yes No ⤷  Subscribe ⤷  Subscribe Y Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,745,409

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1594517 ⤷  Subscribe 300593 Netherlands ⤷  Subscribe
European Patent Office 1594517 ⤷  Subscribe C300593 Netherlands ⤷  Subscribe
European Patent Office 1594517 ⤷  Subscribe CA 2013 00026 Denmark ⤷  Subscribe
European Patent Office 1594517 ⤷  Subscribe PA2013013 Lithuania ⤷  Subscribe
European Patent Office 1594517 ⤷  Subscribe 92200 Luxembourg ⤷  Subscribe
European Patent Office 1594517 ⤷  Subscribe 1390024-6 Sweden ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.